Position history for CAPITAL FUND MANAGEMENT S.A.'s holdings in BIOCRYST PHARMACEUTICALS INC
CAPITAL FUND MANAGEMENT S.A. previously held 0 shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $0 as of 2025-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$1.5M
Total Shares Change
-247,540
Other major holders of BCRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $7.55 |
0 |
| 2025-Q2 | New | 51,913 | - | $465,140 | 0.0% | $9.36 | 33 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $7.86 | 0 |
| 2024-Q4 | Decreased | 59,327 | -83.4% | $446,139 | 0.0% | $7.53 | 0 |
| 2024-Q3 | Increased | 357,615 | +44.5% | $2.7M | 0.0% | $7.62 | 36 |
| 2024-Q2 | Increased | 247,540 | +17.0% | $1.5M | 0.0% | $6.18 | 30 |